Active Ingredient
Active ingredients: Octocrylene 5.00%, Homosalate 5.00%, Ethylhexyl Salicylate 4.50%, Butyl Methoxydibenzoylmethane 4.00%, Ethylhexyl Methoxycinnamate 3.50%
Tako Pore Sebum Sun
FDA Label NDC 59078-326
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Tony Moly Co.,ltd for the product Tako Pore Sebum Sun (NDC 59078-326). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, inactive ingredient, purpose, warnings, description, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
Inactive ingredients:
Dimethicone, Polyethylene, Ethylhexyl Palmitate, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, Diphenylsiloxy Phenyl Trimethicone, Microcrystalline Wax, Polysilicone-15, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Fragrance, Tocopheryl Acetate, Caprylyl Glycol, Eclipta Prostrata Extract, Melia Azadirachta Leaf Extract, Moringa Oleifera Seed Oil, Water, Panthenol, Calamine, Nelumbo Nucifera Flower Water, Sea Water, Centella Asiatica Extract, 1,2-Hexanediol, Algae Extract, Chlorella Vulgaris Extract, Hizikia Fusiforme Extract, Hydrolyzed Collagen
Purpose
Purpose: Sunscreen
Warnings
Warnings:
For external use only
Avoid contact with eyes.
Discontinue use if signs of irritation or rashes appear.
Replace the cap after use.
Keep Out of Reach of Children
Description
Uses:
- helps prevent sunburn
- If used as directed with other sun protection measures
Directions:
Take an appropriate amount, evenly apply to face and body anywhere to be exposed to UV rays. Use as the last step of basic skin care.
* Please review the disclaimer below.
